Literature DB >> 12350062

Human brucellosis.

John M Sauret1, Natalia Vilissova.   

Abstract

BACKGROUND: Human brucellosis has a serious medical impact worldwide, and its eradication poses major difficulties. Although human brucellosis is relatively rare in the United States (approximately 100 cases per year), there is concern that this disease is largely underdiagnosed and underreported. Additionally, immigrants from endemic areas are arriving to this country, and Brucella species are considered to be biologic agents for terrorism. Human brucellosis affects all age-groups, and family physicians are not well versed in recognizing and treating this potentially life-threatening condition.
METHODS: A literature review from 1975 to 2001 was performed using the key words "human brucellosis," "zoonosis," and "bioterrorism." RESULTS AND
CONCLUSIONS: Appropriate antimicrobial therapy and duration of treatment of human brucellosis will reduce morbidity, prevent complications, and diminish relapses. Because of the nonspecific symptoms and rarity of human brucellosis in the United States, family physicians must acquire a detailed dietary and occupational history to diagnose the disease promptly. Family physicians must assume a responsible role in reporting this disease, as well as be aware of persons at high-risk for this disease and the potential sources of infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12350062

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  19 in total

1.  IFN-γ-deficient mice develop IL-1-dependent cutaneous and musculoskeletal inflammation during experimental brucellosis.

Authors:  Jerod A Skyberg; Theresa Thornburg; Irina Kochetkova; William Layton; Gayle Callis; MaryClare F Rollins; Carol Riccardi; Todd Becker; Sarah Golden; David W Pascual
Journal:  J Leukoc Biol       Date:  2012-05-25       Impact factor: 4.962

2.  The Microbial Rosetta Stone Database: a compilation of global and emerging infectious microorganisms and bioterrorist threat agents.

Authors:  David J Ecker; Rangarajan Sampath; Paul Willett; Jacqueline R Wyatt; Vivek Samant; Christian Massire; Thomas A Hall; Kumar Hari; John A McNeil; Cornelia Büchen-Osmond; Bruce Budowle
Journal:  BMC Microbiol       Date:  2005-04-25       Impact factor: 3.605

3.  Epidemiological characteristics of brucellosis in Federation of Bosnia and Herzegovina.

Authors:  Zarema Obradović; Ramiz Velić
Journal:  Croat Med J       Date:  2010-08       Impact factor: 1.351

4.  Syndrome of inappropriate secretion of antidiuretic hormone cholestasis and pericardial effusion due to brucellosis infection: a case report.

Authors:  Ahmet Cumhur Dülger; Ozgür Kemik; Aziz Sümer; Hüseyin Akdeniz; Mehmet Emin Küçükoğlu; Esra Turan Canbaz; Veyis Itik; Enver Aytemiz
Journal:  Case Rep Med       Date:  2010-08-09

5.  Development of Vaccines against Visceral Leishmaniasis.

Authors:  Krystal J Evans; Lukasz Kedzierski
Journal:  J Trop Med       Date:  2011-09-05

6.  Application of polymerase chain reaction to detect burkholderia pseudomallei and Brucella species in buffy coat from patients with febrile illness among rural and peri-urban population.

Authors:  Balaji Nandagopal; Sathish Sankar; Karthikeyan Lingesan; Kc Appu; Gopalan Sridharan; Anilkumar Gopinathan
Journal:  J Glob Infect Dis       Date:  2012-01

7.  Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

Authors:  Jerome S Harms; Marina A Durward; Diogo M Magnani; Gary A Splitter
Journal:  J Immune Based Ther Vaccines       Date:  2009-01-06

8.  ATP-Binding Cassette Systems of Brucella.

Authors:  Dominic C Jenner; Elie Dassa; Adrian M Whatmore; Helen S Atkins
Journal:  Comp Funct Genomics       Date:  2010-02-11

9.  Ocular involvement of brucellosis.

Authors:  Nooshin Bazzazi; Alireza Yavarikia; Fariba Keramat
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jan-Mar

10.  Development of Leishmania vaccines: predicting the future from past and present experience.

Authors:  Joshua Muli Mutiso; John Chege Macharia; Maria Ndunge Kiio; James Maina Ichagichu; Hitler Rikoi; Michael Muita Gicheru
Journal:  J Biomed Res       Date:  2012-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.